(Q38230162)

31 August 2017

title

Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism (English)

1 reference

inflammatory bowel diseases

31 August 2017

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ornella Cominetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Patrizia Brigidi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Paolo Gionchetti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Marco Candela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Emil Chuang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Colleen Draper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ivan Montoliu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Denis Barron

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Martin Kussmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Francois-Pierre J Martin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

1 November 2014

1 reference

Inflammatory Bowel Diseases

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

2104-2114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the management of inflammatory bowel disease in adults

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Towards a 'cure' for IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Microbes in gastrointestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Gut-brain axis: how the microbiome influences anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The long-term stability of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Intestinal microbiota is a plastic factor responding to environmental changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Inflammation and colorectal cancer, when microbiota-host mutualism breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The impact of network medicine in gastroenterology and hepatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Using metabolomic analysis to understand inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Proteomics and metabolomics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Impact of exome sequencing in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabolomic applications to decipher gut microbial metabolic influence in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The nutrition researcher cohort: toward a new generation of nutrition research and health optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabolomics reveals metabolic biomarkers of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Panorganismal gut microbiome-host metabolic crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Gut microbial activity, implications for health and disease: the potential role of metabolite analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Functional interactions between the gut microbiota and host metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The interaction between bacteria and bile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Bile acid receptors as targets for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Taste receptors in the gastrointestinal tract. II. L-amino acid sensing by calcium-sensing receptors: implications for GI physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Minireview: Nutrient sensing by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Broad-spectrum L-amino acid sensing by class 3 G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabolomics view on gut microbiome modulation by polyphenol-rich foods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Hippurate: the natural history of a mammalian-microbial cometabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Indole as an intercellular signal in microbial communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Effects of dietary fiber on inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

A vegan or vegetarian diet substantially alters the human colonic faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

IBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

The Footprints of Gut Microbial–Mammalian Co-Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000116

10.1097/MIB.0000000000000116

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029616%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference